Drug-induced Genetic Mutation: a Descriptive Study
LATIN AMERICAN JOURNAL OF PHARMACY(2022)
摘要
Adverse medication reactions are one of the main challenges that patients face throughout pharmacological treatment. The FDA's post-marketing safety surveillance program for pharmaceuticals and therapeutic biologic products is intended to be aided by the FAERS database. This was a retrospective, descriptive analysis that was conducted to analyze drug-induced genetic mutation from the FDA Adverse Event Reporting System. One thousand five hundred sixty-five reports were submitted to FAERS. The most reported med-ications were imatinib mesylate (15.14%), lamivudine (7.41%), cyclophosphamide (6.65%), nilotinib (5.62%), dasatinib (4.66%), eculizumab (4.54%), rituximab (4.41%), tenofovir disoproxil fumarate (3.83%), etoposide (3.51%), doxorubicin (3.45%), and prednisone (3.32%). It is necessary to continue and systematically monitor the safety of these medications to avoid unnecessary adverse events. Health care providers should report these adverse events to pharmacovigilance systems.
更多查看译文
关键词
adverse events,FAERS,genetic mutation,reporting
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要